IP Library Granted Patent US 7,087,379
Granted Patent B2
US 7,087,379 · App. 09/863,125 · Granted Aug 8, 2006

Method of detecting single gene copies in-situ

Assignee: Ventana Medical Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,087,379
App. No.
09/863,125
Granted
Aug 8, 2006
Kind
B2
Abstract

A method for detecting single copies of a gene in-situ using brightfield microscopy is used in detection of nucleic acid sequences. Probes are directly or indirectly labeled with alkaline phosphatase with NBT/BCIP used as the chromogen.

Claims (8)

1. A method of visually detecting a single copy of the Her-2/neu gene in chromosomal DNA in an intact cell using brightfield microscopy, comprising:

heating the tissue or cell sample sufficiently to dissociate the native chromosomal target strands of Her-2/neu DNA;

contacting said tissue or cell sample with a digoxigenin-labeled nucleic acid Her-2/neu probe specific for the Her-2/neu gene under conditions that allow the re-hybridization of the labeled nucleic acid Her-2/neu probe and target strands of Her-2/neu DNA to form a target-probe duplex;

contacting the target-probe duplex with an anti-digoxigenin antibody under conditions allowing the antibody to bind to the label;

contacting the anti-digoxigenin antibody with an enzyme and a chromogen composition under conditions allowing the development of a visually detectable chromogen substrate signal at each target-probe duplex in the nucleus of the intact cell separate and distinct from the chromogenic signals of other copies of said chromosomal target nucleic acid sequence; and

detecting the chromogenic substrate signal visually using brightfield microscope conditions.

2. The method of claim 1 wherein the enzyme is selected from the group consisting of a phosphatase and a peroxidase.

3. The method of claim 1 wherein the chromogen is selected from the group consisting of NBT/BCIP, tetramethylbenzidine and diamino benzidine.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2005
From: LIGHT, ELIZABETH S.
To: VENTANA MEDICAL SYSTEMS, INC.
Reel/Frame 016598/0868 →
Continuity (2)
Continuation 0941942100 · Oct 15, 1999
Related Publication 20020019001A1 · Feb 14, 2002